Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE) EBIT: ₺76.9 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ARFYE Arf Bio Yenilenebilir Enerji Uretim AS IST:ARFYE
16 GF Score
Price ₺31.30
! 5 Warning Signs
View Full Analysis

What is Arf Bio Yenilenebilir Enerji Uretim AS EBIT?

Arf Bio Yenilenebilir Enerji Uretim AS IST:ARFYE -0.89% 16 EBIT is ₺76.9 Mil as of Mar. 2026. GuruFocus rates IST:ARFYE with a GF Score™ of 16/100. The stock has 5 warning signs investors should review.

Arf Bio Yenilenebilir Enerji Uretim AS's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₺76.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₺76.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Arf Bio Yenilenebilir Enerji Uretim AS's annualized ROC % for the quarter that ended in Mar. 2026 was 0.44%. Arf Bio Yenilenebilir Enerji Uretim AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 17.94%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Arf Bio Yenilenebilir Enerji Uretim AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.46%.

Arf Bio Yenilenebilir Enerji Uretim AS  (IST:ARFYE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Arf Bio Yenilenebilir Enerji Uretim AS's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=30.272 * ( 1 - 73.51% )/( (1837.079 + 1809.488)/ 2 )
=8.0190528/1823.2835
=0.44 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1907.148 - 63.577 - ( 6.492 - max(0, 273.762 - 622.897+6.492))
=1837.079

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2679.668 - 79.596 - ( 790.584 - max(0, 289.953 - 1311.773+790.584))
=1809.488

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Arf Bio Yenilenebilir Enerji Uretim AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=307.608/( ( (1181.218 + max(549.514, 0)) + (1257.784 + max(440.579, 0)) )/ 2 )
=307.608/( ( 1730.732 + 1698.363 )/ 2 )
=307.608/1714.5475
=17.94 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(576.714 + 29.961 + 9.5580000000001) - (63.577 + 0 + 3.142)
=549.514

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(342.098 + 49.068 + 130.023) - (79.596 + 0 + 1.014)
=440.579

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Arf Bio Yenilenebilir Enerji Uretim AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=76.902/5260.492
=1.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arf Bio Yenilenebilir Enerji Uretim AS EBIT Related Terms

Arf Bio Yenilenebilir Enerji Uretim AS EBIT Historical Data

* Premium members only.

The historical data trend for Arf Bio Yenilenebilir Enerji Uretim AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arf Bio Yenilenebilir Enerji Uretim AS EBIT Chart

Arf Bio Yenilenebilir Enerji Uretim AS Annual Data
Trend Dec22 Dec23 Dec24
EBIT
21.89 136.65 58.48

Arf Bio Yenilenebilir Enerji Uretim AS Quarterly Data
Dec22 Dec23 Dec24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial 0.00 59.24 -17.76 0.00 76.90

Arf Bio Yenilenebilir Enerji Uretim AS EBIT Competitor Comparison

For the Utilities - Renewable subindustry, Arf Bio Yenilenebilir Enerji Uretim AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arf Bio Yenilenebilir Enerji Uretim AS EV-to-EBIT vs Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Arf Bio Yenilenebilir Enerji Uretim AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Arf Bio Yenilenebilir Enerji Uretim AS's EV-to-EBIT falls into.


IST:ARFYE
16GF Score
Arf Bio Yenilenebilir Enerji Uretim AS IST:ARFYE
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arf Bio Yenilenebilir Enerji Uretim AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺76.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₺76.9 Mil mean?
Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE) has a EBIT of ₺76.9 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Arf Bio Yenilenebilir Enerji Uretim AS.
Is Arf Bio Yenilenebilir Enerji Uretim AS's EBIT too high?
Arf Bio Yenilenebilir Enerji Uretim AS's current EBIT is ₺76.9 Mil. Overall, Arf Bio Yenilenebilir Enerji Uretim AS has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Arf Bio Yenilenebilir Enerji Uretim AS's EBIT compare to competitors?
Arf Bio Yenilenebilir Enerji Uretim AS's EBIT of ₺76.9 Mil can be compared against companies in the Utilities - Independent Power Producers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Utilities - Independent Power Producers company?
A good EBIT depends on the Utilities - Independent Power Producers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Arf Bio Yenilenebilir Enerji Uretim AS. Arf Bio Yenilenebilir Enerji Uretim AS's current EBIT is ₺76.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arf Bio Yenilenebilir Enerji Uretim AS stock overvalued right now?
Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE) has a current EBIT of ₺76.9 Mil. The current EBIT is ₺76.9 Mil. Arf Bio Yenilenebilir Enerji Uretim AS's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Arf Bio Yenilenebilir Enerji Uretim AS (IST:ARFYE), the current EBIT is ₺76.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arf Bio Yenilenebilir Enerji Uretim AS Business Description

Address Nergiz Street, No: 9/36, Bestepe Neighborhood, Yenimahalle, Ankara, TUR
Arf Bio Yenilenebilir Enerji Uretim AS operates in the renewable energy sector. The company is engaged in biomass sector that focused on transforming waste that causes environmental pollution into efficient end products. its Biogas Technology enables the generation of energy from organic waste materials, increases soil fertility with organic-organomineral fertilizers, and generation of electricity.
16GF Score

Get the complete analysis for IST:ARFYE

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺31.30
Price